The results of a University of Maryland (UMD)-led study could point to new and improved treatment approaches for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder that causes ...
The Progeria Research Foundation ("PRF"), a nonprofit research organization dedicated to developing treatments and the cure ...
A University of Maryland-led discovery could spur the development of new and improved treatments for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder with no known cure that causes ...
Sentynl will acquire full rights to the investigational drug candidate, Progerinin (SLC-D011), adding to its commercial portfolio of rare and ultra-rare disease products AHMEDABAD, India and SOLANA ...
Sentynl, a subsidiary of Zydus Lifesciences, entered into a licensing agreement with PRG S&T for Progerinin (SLC-D011), an ...
Zydus Lifesciences' subsidiary, Sentynl Therapeutics, has licensed the experimental molecule Progerinin to treat ...
Study used cell lines obtained from the Progeria Research Foundation to evaluate Telomir-1’s effects on key drivers of accelerated aging MIAMI, FLORIDA / ACCESS Newswire / June 18, 2025 / Telomir ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results